BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 23150340)

  • 1. Interactions between the tumor suppressor p53 and immune responses.
    Menendez D; Shatz M; Resnick MA
    Curr Opin Oncol; 2013 Jan; 25(1):85-92. PubMed ID: 23150340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human TLR innate immune gene family is differentially influenced by DNA stress and p53 status in cancer cells.
    Shatz M; Menendez D; Resnick MA
    Cancer Res; 2012 Aug; 72(16):3948-57. PubMed ID: 22673234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulatory Function of the Tumor Suppressor p53 in Host Immune Response and the Tumor Microenvironment.
    Cui Y; Guo G
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27869779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation therapy and Toll-like receptor signaling: implications for the treatment of cancer.
    Roses RE; Xu M; Koski GK; Czerniecki BJ
    Oncogene; 2008 Jan; 27(2):200-7. PubMed ID: 18176601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 amplifies Toll-like receptor 5 response in human primary and cancer cells through interaction with multiple signal transduction pathways.
    Shatz M; Shats I; Menendez D; Resnick MA
    Oncotarget; 2015 Jul; 6(19):16963-80. PubMed ID: 26220208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoids and the innate immune system: crosstalk with the toll-like receptor signaling network.
    Chinenov Y; Rogatsky I
    Mol Cell Endocrinol; 2007 Sep; 275(1-2):30-42. PubMed ID: 17576036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innate immunity and cancer therapy.
    Maruyama K; Selmani Z; Ishii H; Yamaguchi K
    Int Immunopharmacol; 2011 Mar; 11(3):350-7. PubMed ID: 20955832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand dependent restoration of human TLR3 signaling and death in p53 mutant cells.
    Menendez D; Lowe JM; Snipe J; Resnick MA
    Oncotarget; 2016 Sep; 7(38):61630-61642. PubMed ID: 27533082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Toll-like receptor gene family is integrated into human DNA damage and p53 networks.
    Menendez D; Shatz M; Azzam K; Garantziotis S; Fessler MB; Resnick MA
    PLoS Genet; 2011 Mar; 7(3):e1001360. PubMed ID: 21483755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptors and immune regulation: implications for cancer therapy.
    Wang RF; Miyahara Y; Wang HY
    Oncogene; 2008 Jan; 27(2):181-9. PubMed ID: 18176599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of TLR expression, a new perspective for the role of VIP in immunity.
    Gomariz RP; Arranz A; Juarranz Y; Gutierrez-Cañas I; Garcia-Gomez M; Leceta J; Martínez C
    Peptides; 2007 Sep; 28(9):1825-32. PubMed ID: 17706836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory T cells and innate immune regulation in tumor immunity.
    Wang RF
    Springer Semin Immunopathol; 2006 Aug; 28(1):17-23. PubMed ID: 16838179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autophagy in regulation of Toll-like receptor signaling.
    Into T; Inomata M; Takayama E; Takigawa T
    Cell Signal; 2012 Jun; 24(6):1150-62. PubMed ID: 22333395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tumor suppressor ARF regulates innate immune responses in mice.
    Través PG; López-Fontal R; Luque A; Hortelano S
    J Immunol; 2011 Dec; 187(12):6527-38. PubMed ID: 22095712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of Toll-like receptor signaling pathways in innate immune responses.
    Qian C; Cao X
    Ann N Y Acad Sci; 2013 Apr; 1283():67-74. PubMed ID: 23163321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signaling to NF-kappaB by Toll-like receptors.
    Kawai T; Akira S
    Trends Mol Med; 2007 Nov; 13(11):460-9. PubMed ID: 18029230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TLR signaling.
    Kawai T; Akira S
    Semin Immunol; 2007 Feb; 19(1):24-32. PubMed ID: 17275323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.
    Smith ND; Rubenstein JN; Eggener SE; Kozlowski JM
    J Urol; 2003 Apr; 169(4):1219-28. PubMed ID: 12629332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cooperation of Toll-like receptor signals in innate immune defence.
    Trinchieri G; Sher A
    Nat Rev Immunol; 2007 Mar; 7(3):179-90. PubMed ID: 17318230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.